Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
The Global Market for Synthetic Oligonucleotides
Oligonucleotides (oligos) represent an important market for life science suppliers because they are an indispensable and ubiquitous tool for scientists working with DNA and/or RNA. As the overall market for oligos is considered mature, suppliers are challenged to distinguish their brand from the many others available to scientists. To help suppliers meet this challenge, we present the opinions of over 700 scientists who use oligos in their research, including what they expect from their oligos and which suppliers they buy from for their different research applications.
Building upon the success of our 2004 report on The U.S. Market for Synthetic Oligonucleotides, this report will examine the worldwide market for oligos.
Report Objectives
From the perspective of researchers who use DNA and/or RNA oligonucleotides, this report:
> Determines overall market size for DNA oligos in the U.S. and in Europe
> Highlights research trends driving the demand for oligos
> Details preferred oligo purchasing channels
> Reveals market specific differences in usage of oligo-based techniques by segmentation analysis
> Identifies leading oligo suppliers by relative customer expenditure
> Provides market size and share estimates for the leading DNA oligo suppliers
> Assesses market growth potential over the next 12 months by market segmentation analysis for DNA oligos
> Pinpoints which specialty services scientists require and determine their preferred formats and costs
> Provides insights into which product attributes contribute to customer satisfaction and customer dissatisfaction
> Evaluates brand equity based upon key performance metrics related to brand esteem, knowledge, relevance, and differentiation
September 2006 Pages 171
Price
Printed copy $4,000.00
Enterprise wide PDF + Print copy $6,000.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.